Tokyo Tape
Sign in
← GNI Group

Half-year report · Q2

2160.TEDINET S100WJCL
Period2025-01-01 → 2025-06-30
Filed2025-08-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥12.3bn2025-01-01 → 2025-06-30Cons.Revenue IFRS
Revenue¥23.6bn2024-01-01 → 2024-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥11.7bn2024-01-01 → 2024-06-30Cons.Revenue IFRS
Operating income−¥1.2bn2025-01-01 → 2025-06-30Cons.Operating profit loss IFRS
Operating income¥1.8bn2024-01-01 → 2024-06-30Cons.Operating profit loss IFRS
Profit before tax−¥1.4bn2025-01-01 → 2025-06-30Cons.Profit loss before tax IFRS
Profit before tax¥238m2024-01-01 → 2024-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥831m2024-01-01 → 2024-06-30Cons.Profit loss before tax IFRS
Net income (owners)−¥915m2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥1.1bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥330m2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥2.3bn2025-01-01 → 2025-06-30Cons.Profit loss IFRS
Net income−¥10m2024-01-01 → 2024-12-31Cons.Profit loss IFRS (5-year summary)
Net income−¥74m2024-01-01 → 2024-06-30Cons.Profit loss IFRS
Total assets¥67.7bnat 2025-06-30Cons.Assets IFRS
Total assets¥71.9bnat 2024-12-31Cons.Assets IFRS
Total assets¥69.0bnat 2024-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥29.4bnat 2025-06-30Cons.Liabilities IFRS
Total liabilities¥32.2bnat 2024-12-31Cons.Liabilities IFRS
Net assets / equity¥38.3bnat 2025-06-30Cons.Equity IFRS
Net assets / equity¥39.7bnat 2024-12-31Cons.Equity IFRS
Net assets / equity¥40.0bnat 2024-06-30Cons.Equity IFRS
Net assets / equity¥36.5bnat 2023-12-31vCons.Equity IFRS
Equity (owners)¥35.3bnat 2025-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥36.4bnat 2024-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥36.8bnat 2024-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥10.5bnat 2025-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥10.1bnat 2024-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥16.3bnat 2024-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥21.6bnat 2023-12-31vCons.Cash and cash equivalents IFRS
Operating cash flow−¥932m2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥3.2bn2024-01-01 → 2024-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥1.5bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥632m2025-01-01 → 2025-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥10.4bn2024-01-01 → 2024-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥5.5bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥1.4bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥694m2024-01-01 → 2024-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥186m2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-18.192025-01-01 → 2025-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥21.962024-01-01 → 2024-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥6.612024-01-01 → 2024-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-18.192025-01-01 → 2025-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥21.152024-01-01 → 2024-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥6.372024-01-01 → 2024-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio52.1%at 2025-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio50.7%at 2024-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio53.4%at 2024-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E05712-000Medical Devicereportable segmentrevenue2025-01-01 → 2025-06-30¥4.1bn
jpcrp040300-q2r_E05712-000Medical Devicereportable segmentrevenue external2025-01-01 → 2025-06-30¥4.1bn
jpcrp040300-q2r_E05712-000Medical Devicereportable segmentsegment profit2025-01-01 → 2025-06-30¥503m
jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segmentrevenue2025-01-01 → 2025-06-30¥8.2bn
jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segmentrevenue external2025-01-01 → 2025-06-30¥8.2bn
jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segmentsegment profit2025-01-01 → 2025-06-30−¥1.7bn
—segment totalrevenue2025-01-01 → 2025-06-30¥12.3bn
—segment totalrevenue external2025-01-01 → 2025-06-30¥12.3bn
—segment totalsegment profit2025-01-01 → 2025-06-30−¥1.2bn
jpcrp040300-q2r_E05712-000Medical Devicereportable segmentrevenue2024-01-01 → 2024-06-30¥2.6bn
jpcrp040300-q2r_E05712-000Medical Devicereportable segmentrevenue external2024-01-01 → 2024-06-30¥2.6bn
jpcrp040300-q2r_E05712-000Medical Devicereportable segmentsegment profit2024-01-01 → 2024-06-30¥676m
jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segmentrevenue2024-01-01 → 2024-06-30¥9.1bn
jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segmentrevenue external2024-01-01 → 2024-06-30¥9.1bn
jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segmentsegment profit2024-01-01 → 2024-06-30¥1.1bn
—segment totalrevenue2024-01-01 → 2024-06-30¥11.7bn
—segment totalrevenue external2024-01-01 → 2024-06-30¥11.7bn
—segment totalsegment profit2024-01-01 → 2024-06-30¥1.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 716
ItemContextValueUnit
Other current liabilities cl IFRSCurrentQuarterInstant2612282000JPY
Total current liabilities IFRSPrior1YearInstant12464403000JPY
Total current liabilities IFRSCurrentQuarterInstant10404696000JPY
Liabilities IFRSPrior1YearInstant32229009000JPY
Liabilities IFRSCurrentQuarterInstant29408573000JPY
Share capital IFRSPrior1YearInstant13276700000JPY
Share capital IFRSCurrentQuarterInstant13463507000JPY
Capital surplus IFRSPrior1YearInstant6626254000JPY
Capital surplus IFRSCurrentQuarterInstant8874885000JPY
Treasury shares IFRSPrior1YearInstant-15372000JPY
Treasury shares IFRSCurrentQuarterInstant-15629000JPY
Retained earnings IFRSPrior1YearInstant9888797000JPY
Retained earnings IFRSCurrentQuarterInstant8973417000JPY
Other components of equity IFRSPrior1YearInstant6669736000JPY
Other components of equity IFRSCurrentQuarterInstant3973112000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant36446115000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant35269293000JPY
Non controlling interests IFRSPrior1YearInstant3267785000JPY
Non controlling interests IFRSCurrentQuarterInstant3044309000JPY
Equity IFRSPrior1YearInstant39713900000JPY
Equity IFRSCurrentQuarterInstant38313602000JPY
Liabilities and equity IFRSPrior1YearInstant71942909000JPY
Liabilities and equity IFRSCurrentQuarterInstant67722176000JPY
Revenue IFRSPrior1YTDDuration11733821000JPY
Revenue IFRSCurrentYTDDuration12252326000JPY
Cost of sales IFRSPrior1YTDDuration2165775000JPY
Cost of sales IFRSCurrentYTDDuration3418539000JPY
Gross profit IFRSPrior1YTDDuration9568045000JPY
Gross profit IFRSCurrentYTDDuration8833786000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration7117436000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration7995729000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration1419327000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration1596527000JPY
Other income IFRSPrior1YTDDuration1909702000JPY
Other income IFRSCurrentYTDDuration322074000JPY
Other expenses IFRSPrior1YTDDuration1178841000JPY
Other expenses IFRSCurrentYTDDuration743143000JPY
Operating profit loss IFRSPrior1YTDDuration1762142000JPY
Operating profit loss IFRSCurrentYTDDuration-1179539000JPY
Finance income IFRSPrior1YTDDuration371879000JPY
Finance income IFRSCurrentYTDDuration539301000JPY
Finance costs IFRSPrior1YTDDuration1343366000JPY
Finance costs IFRSCurrentYTDDuration794831000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration40735000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration1118000JPY
Profit loss before tax IFRSPrior1YTDDuration831391000JPY
Profit loss before tax IFRSCurrentYTDDuration-1433950000JPY
Income tax expense IFRSPrior1YTDDuration905241000JPY
Income tax expense IFRSCurrentYTDDuration908797000JPY
Profit loss IFRSPrior1YTDDuration-73850000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-12-31pass
balance sheet identityconsolidated 2025-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass